← back to search

Khurram Jamil

Rodin Therapeutics (United States) · US
Area of research
Hepatology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Liver Disease and Transplantation, Electrolyte and hormonal disorders, Liver Disease Diagnosis and Treatment, and Organ Transplantation Techniques and Outcomes.
h-index
16
citations
1,614
works
97
NIH funding
primary concept
Terlipressin
email

Recent publications

A constrained disorder principle-based second-generation artificial intelligence digital medical cannabis system: A real-world data analysis
Journal of public health research 2025cited by 4position: middledoi
Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase <scp>III</scp> Clinical Studies
Alimentary Pharmacology & Therapeutics 2025cited by 3position: middledoi
A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial
Biomedicine & Pharmacotherapy 2023cited by 38position: middledoi
Pharmacokinetics/pharmacodynamics of L‐ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes
Clinical and Translational Science 2022cited by 20position: middledoi
Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome
Nephrology Dialysis Transplantation 2019cited by 29position: lastdoi
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the <scp>OT</scp>‐0401 and <scp>REVERSE</scp> randomised clinical studies
Alimentary Pharmacology & Therapeutics 2017cited by 100position: lastdoi
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1
Gastroenterology 2016cited by 303position: middledoi
Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome
Clinical Gastroenterology and Hepatology 2016cited by 66position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Florence Wong · GTx (United States)4 papers (2016–2025)S. Chris Pappas · Swedish Orphan Biovitrum (United States)4 papers (2016–2025)Shannon Escalante · Mallinckrodt (Ireland)3 papers (2016–2019)Jasmohan S. Bajaj · Virginia Commonwealth University3 papers (2016–2025)Arun J. Sanyal · Center for Systems Biology3 papers (2016–2019)Thomas Boyer · University of Arizona3 papers (2016–2019)Noa Hurvitz · Hebrew University of Jerusalem2 papers (2023–2025)Marc Berg · Palo Alto University2 papers (2023–2025)Samuel Agus · Palo Alto University2 papers (2023–2025)Yaron Ilan · Hebrew University of Jerusalem2 papers (2023–2025)Yotam Kolben · Hebrew University of Jerusalem2 papers (2023–2025) · 1 papers (2022–2022)Dean Nachman · Hebrew University of Jerusalem1 papers (2023–2023) · 1 papers (2023–2023)Stan Bukofzer · Virginia Commonwealth University1 papers (2022–2022)Rifaat Safadi · Hadassah Medical Center1 papers (2022–2022)Suhail Aamar · Hebrew University of Jerusalem1 papers (2025–2025)R. Todd Frederick · California Pacific Medical Center1 papers (2017–2017)Lorenzo Rossaro · University of California, Davis1 papers (2017–2017) · 1 papers (2017–2017)